Hau L, Firkin B G, Howard M A
Br J Haematol. 1986 Mar;62(3):479-85. doi: 10.1111/j.1365-2141.1986.tb02959.x.
The binding capacity of radiolabelled human alpha-thrombin (alpha-thrombin), inactivated with phenyl-methyl sulphonyl fluoride (PMSF), to factor VIII related antigen (VIII:RAg) multimers isolated by immune precipitation and resolved by sodium dodecyl sulphate (SDS) agarose gel electrophoresis has been examined. 125I-PMSF alpha-thrombin bound predominantly to four low molecular weight multimers (LMW) of VIII:RAg prepared from either normal or haemophilia A plasma. Two of these VIII:RAg multimers present in serum had lost the capacity to bind thrombin. No bands were observed when either plasma or serum from three patients with severe von Willebrand's disease (vWd) was processed in an identical manner. This binding was not dependent on the presence of an intact catalytic site on the thrombin molecule. A similar pattern of binding to VIII:RAg multimers was observed with 125I-labelled human anti-FVIII antibodies as 125I-alpha-thrombin and appears to involve the same multimers.
已对用苯甲基磺酰氟(PMSF)灭活的放射性标记人α-凝血酶(α-凝血酶)与通过免疫沉淀分离并用十二烷基硫酸钠(SDS)琼脂糖凝胶电泳解析的因子VIII相关抗原(VIII:RAg)多聚体的结合能力进行了检测。125I-PMSFα-凝血酶主要与由正常或甲型血友病血浆制备的VIII:RAg的四种低分子量多聚体(LMW)结合。血清中存在的这些VIII:RAg多聚体中有两种已失去结合凝血酶的能力。当以相同方式处理三名重度血管性血友病(vWd)患者的血浆或血清时,未观察到条带。这种结合不依赖于凝血酶分子上完整催化位点的存在。与125I-α-凝血酶一样,用125I标记的人抗FVIII抗体观察到与VIII:RAg多聚体的类似结合模式,并且似乎涉及相同的多聚体。